A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogen
Author:
Publisher
Elsevier BV
Subject
Cell Biology
Reference65 articles.
1. The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
2. Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk
3. Aromatase inhibitors for breast cancer: lessons from the laboratory
4. Selective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice
5. Crosstalk Between IGF1R and Estrogen Receptor Signaling in Breast Cancer
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potential therapeutic role for pigment epithelium-derived factor in post-menopausal breast cancer bone metastasis;Journal of Pharmacy and Pharmacology;2023-04-28
2. Functional Validation of the Putative Oncogenic Activity of PLAU;Biomedicines;2022-12-30
3. uPAR, beyond regulating physiological functions, has orchestrated roles in cancer (Review);International Journal of Oncology;2022-10-18
4. Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer;Journal of Translational Medicine;2022-03-18
5. Urokinase Receptor uPAR Downregulation in Neuroblastoma Leads to Dormancy, Chemoresistance and Metastasis;Cancers;2022-02-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3